Thin R N
Department of Genito-urinary Medicine, St. Thomas' Hospital, London, United Kingdom.
Am J Med. 1988 Aug 29;85(2A):3-6.
Genital herpes simplex infection is a common and troublesome condition that is more often due to herpes simplex type II virus than to type I virus. The first step in management is accurate diagnosis by virus culture or antigen recognition. General management involves explaining the natural history to the patient, giving advice on sexual behavior, contact tracing, and hygiene. Oral or intravenous acyclovir provides the most useful therapy for first attacks. Acyclovir cream has a similar effect with external lesions in mild attacks. A course of acyclovir, however, has no effect on subsequent recurrence. Recurrent attacks, being brief compared with first attacks, are less influenced by acyclovir therapy, which should be given early for maximal effect. Oral and intravenous therapy are effective in the treatment of genital and anal herpes simplex infection in patients with acquired immune deficiency syndrome. When oral therapy is used, doses may need to be increased. Acyclovir therapy is a valuable development compared with previously available antivirals for genital herpes simplex infection.
单纯疱疹病毒生殖器感染是一种常见且棘手的病症,更多情况下是由II型单纯疱疹病毒而非I型病毒引起。治疗的第一步是通过病毒培养或抗原识别进行准确诊断。一般治疗包括向患者解释疾病的自然病程,提供性行为、接触者追踪和卫生方面的建议。口服或静脉注射阿昔洛韦对首次发作提供了最有效的治疗。阿昔洛韦乳膏对轻度发作的外部病损有类似效果。然而,一个疗程的阿昔洛韦对后续复发没有作用。与首次发作相比,复发发作持续时间较短,受阿昔洛韦治疗的影响较小,应尽早给予以达到最大效果。口服和静脉治疗对获得性免疫缺陷综合征患者的生殖器和肛门单纯疱疹病毒感染有效。当使用口服治疗时,剂量可能需要增加。与先前用于单纯疱疹病毒生殖器感染的抗病毒药物相比,阿昔洛韦治疗是一项有价值的进展。